A Systematic Review of the Evidence Behind Use of Reduced Doses of Acetaminophen in Chronic Liver Disease-Reference-Cited by-同舟云学术

A Systematic Review of the Evidence Behind Use of Reduced Doses of Acetaminophen in Chronic Liver Disease

Published:2018-10-02 Issue:4 Volume:32 Page:226-239
ISSN:1536-0288
Container-title:Journal of Pain & Palliative Care Pharmacotherapy
language:en
Short-container-title:Journal of Pain & Palliative Care Pharmacotherapy

Author:

Schweighardt Anne E.¹^ORCID,Juba Katherine M.¹^ORCID

Affiliation:

1. Anne E. Schweighardt, PharmD, and Katherine M. Juba, PharmD, are with the Department of Pharmacy Practice, Wegmans School of Pharmacy, St. John Fisher College, Rochester, New York, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Anesthesiology and Pain Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15360288.2019.1611692

Reference48 articles.

1. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

2. Kinetics and metabolism of paracetamol and phenacetin.

3. Increased oxidative metabolism of paracetamol in patients with hepatocellular carcinoma

4. Glucuronidation in Humans

5. Paracetamol and metabolite pharmacokinetics in infants

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older;Current Medical Research and Opinion;2022-03-29

2. Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis;Hepatology Communications;2021-08-25

3. Pain Management in Patients with Serious Illness;Medical Clinics of North America;2020-05